Singapore has the second-highest proportion of diabetics (after the US) among developed nations, with 10% of the population aged between 20 and 79 estimated to have the chronic disease. According to the WHO, the number of adults to be living with diabetes in Singapore has nearly quadrupled over 35 years.

The MOH has declared war on diabetes, describing it as one of the biggest burdens on the healthcare system in Singapore, costing more than $1 billion annually.

Since 2016, an international team of scientists at the Lee Kong Chian School of Medicine has been tackling diabetes through a multi-pronged research strategy, with a key focus on Asian populations. The breakthrough research has 3 key priorities: (a) Develop smart drugs that slow down enteric glucose absorption; (b) Advance paper-based diagnostics for pre-diabetes metabolic disease; and (c) Establish rapid immune cell profiling from a single drop of blood from diabetics.

There is no cure for diabetes yet, but with generous support towards our key research as above, there is hope that we can slow down the trend of diabetes in Singapore and accelerate findings for preventive solutions and treatments for diabetes.

All donations go towards diabetes research under the LKCMedicine Healthcare Research Fund. Your support also goes towards the raising of diabetes awareness in Singapore.

Thank you for joining in the fight to win the war against diabetes in Singapore.